BioCentury | Jan 5, 2018
Emerging Company Profile

Against radical pain

...CerSci was founded in 2014 to create non-opioid pain drugs, and acquired its lead candidate, CT-044...
...to prevent respiratory distress following surgery in patients with a history of sleep apnea. However, CT-044...
...preclinical data showing CT-044 can rescue rat models from hypersensitivity to pain. Dax added that CT-044...
Items per page:
1 - 1 of 1